ablation frontiers, atrial fibrillation catheter company, Cardiac Catheters, Atrial Fibrillation Treatment, RF Radiofrequency Ablation Technology, Atrial Fibrillation Clinical
 
Nominated Most Innovative Product
Clinical Studies Show Excellent Outcomes

Published Data

  1. Weber S, Fredersdorf S, Jilek C, Heinicke N, Jungbauer C, Husser O, Jeron A. Isolation Of Pulmonary Veins Using A Novel Decapolar Catheter For Mapping And Ablation. Circ 2008. 118: S_925-b [Abstract 4653].

  2. Murray S, Adam Z, Horne A, Humphries V, Mahjid S. Adoption of a multi-electrode, phased radiofrequency ablation system for atrial fibrillation ablation by a single operator: outcomes and comparison to 3D mapping system guided, double trans-septal technique. Europace 2008; 10 (Supp 2): ii5.

  3. James SA, Shepherd EJ, Gall SA, Neville-Smith KE, Furniss SS, Lord SW, Bourke JP. The impact of novel multi-array catheters on procedure time and outcome for ablation of atrial fibrillation. Europace 2008; 10 (Supp 2): ii23.

  4. Boersma LVA, Scharf C, Davies W, Kanagaratnam P, Paul V, Rowland E, Grace A, Fynn S, Oral H, Morady F. Multi-electrode ablation with duty-cycled low power bipolar/uniplolar RF energy for chronic AF. Eur Heart J 2008;29:410  [Abstract: P2621]

  5. Boersma LVA, Wijffels MCE, Wever EFD, Oral H, Morady F. PV antrum ablation for PAF by duty-cycled bipolar/unipolar RF energy through a novel circular decapolar catheter. Eur Heart J 2008;29:409  [Abstract: P2619]

  6. Wijffels MCEF, Van Oosterhout MF, Vos MA, Beekman JD, Boersma LVA. Characterization of lesions in swine atrium using novel multi-electrode ablation catheters. Eur Heart J 2008;29 (Abstract Suppl):412 [Abstract #: P2632]

  7. Fredersdorf S, Weber S, Jilek C, Jungbauer C, Schneider HJ, Jeron A. Safe And Fast Isolation Of Pulmonary Veins Using A Novel Circular Ablation Catheter. Europace 2008; 10 (Supp 1): i184.

  8. Dang L, Boersma L, Oral H, Morady F, Candinas R, Scharf C. Multi-Electrode Catheters Using Low Energy Phased Radiofrequency For Ablation Of Chronic Atrial Fibrillation. Europace 2008; 10 (Supp 1): i184.

  9. Dang L, Oral H, Morady F, Candinas R, Scharf C. Low energy phased radiofrequency for multielectrode ablation of paroxysmal atrial fibrillation (abstract). Heart Rhythm 2008; 5 (Suppl):S18. [AB9-3]

  10. Boersma LVA, Wijffels MC, Wever EFD, Oral H, Morady F. Clinical efficacy of PV antrum ablation for AF by duty-cycled RF energy thorough a novel circumlinear decapolar catheter (abstract). Heart Rhythm 2008; 5 (Suppl):S19. [AB9-5]

  11. Michaud GF, Martin DT, John RM, Daubert JP, Knight BP, Hummel JD, Kalbfleisch SJ, Weiss R, Hoyt R, Bailin S, Swarup V, Bahu MM.  Safety using novel multi-array catheters and phased radiofrequency energy in left atrial ablation for persisent atrial fibrillation (abstract). Heart Rhythm 2008; 5 (Suppl):S313-314. [PO5-17]

  12. Boersma LVA, Wijffels MC, Wever EFD, Oral H, Morady F. Acute Results of PV antrum albation by a novel circumlinear decapolar catheter with low power duty-cycled RF energy (abstract). Heart Rhythm 2008; 5 (Suppl):S368-369. [PO6-32]

  13. Scharf C, Boersma LVA, Kanagaratnam P, Davies DW, Peters NS, Paul V, Rowland E, Fynn SP, Grace AA. Long Term Efficacy When Using Multi-Array Catheters and Phased Radiofrequency Energy for Ablation of Chronic Atrial Fibrillation (abstract). J Am Coll Cardiol. 2008;51(10):A8. [1008-94]

Cardiac Ablation Catheter Company for Atrial Fibrillation

RF Radiofrequency ablation catheter atrial fibrillation 3D catheter ablation frontiers company Back to top
RF Radiofrequency ablation catheter atrial fibrillation 3D catheter ablation frontiers company Contact
RF Radiofrequency ablation catheter atrial fibrillation 3D catheter ablation frontiers company Home

 
© 2007 Ablation Frontiers, Inc. All Rights Reserved
Caution: Investigational Device, Limited by Federal (U.S.) Law to Investigational Use.  Not available for sale in the United States.
Disclaimer | Privacy Statement | Terms of Use | Investor Information | Site Map
Medical Web Site Design & Management by Vital Element, Inc.